LabCorp 2014 Annual Report Download - page 127

Download and view the complete annual report

Please find page 127 of the 2014 LabCorp annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 128

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128

Corporate Headquarters
531 South Spring Street
Burlington, NC 27215
336-584-5171
Information Sources
Information about LabCorp is available
from the following Company sources:
Investor Relations Contact
Paul Surdez
Vice President, Investor Relations
336-436-5076
Center for Molecular Biology and Pathology
800-345-4363
Center for Occupational Testing
800-833-3984
Center for Esoteric Testing
800-222-7566
Paternity/Identity
800-582-0077
Covance Drug Development
609-452-8550
Websites
www.labcorp.com
www.covance.com
Transfer Agent
American Stock Transfer & Trust Company
Shareholder Services
6201 Fifteenth Avenue
Brooklyn, NY 11219
800-937-5449
www.amstock.com
Independent Registered
Public Accounting Firm
PricewaterhouseCoopers LLP
800 Green Valley Road, Suite 500
Greensboro, NC 27408
Annual Meeting
The annual meeting of shareholders will be held
at 9:00 a.m. EDT on May 13, 2015. The meeting will
be a completely virtual meeting of shareholders
to be held over the Internet, accessible at
www.virtualshareholdermeeting.com/LH2015
by entering your unique control number.
Form 10-K
Copies of Form 10-K as filed with the Securities
and Exchange Commission are available
without cost to shareholders by writing to:
Laboratory Corporation of America Holdings
Investor Relations Department
358 South Main Street
Burlington, NC 27215
To download this Annual Report or the
Company’s Proxy Statement, visit our
website at: www.labcorp.com.
Safe Harbor
Forward-looking statements in this annual
report are subject to change based on various
important factors, including without limitation,
competitive actions in the marketplace and
adverse actions of governmental and other
third-party payers. Actual results could differ
materially from those suggested by these
forward-looking statements. Further information
on potential factors which could affect the
Company’s financial results is included in the
Company’s Form 10-K for the year ended
December 31, 2014, and subsequent filings with
the Securities and Exchange Commission.
Common Stock
The Company’s common stock, par value $0.10
per share (the “Common Stock”), trades on the
New York Stock Exchange (“NYSE”) under the
symbol “LH.” The following table sets forth for
the calendar periods indicated the high and low
sales prices for the Common Stock reported on
the NYSE Composite Tape.
2014 2013
High Low High Low
1Q $102.00 $87.25 $ 91.84 $85.80
2Q $105.38 $95.12 $101.69 $89.68
3Q $108.77 $101.55 $101.92 $95.36
4Q $109.84 $95.61 $108.00 $87.01
Corporate Governance, Code of Business
Conduct and Ethics
The Company’s Corporate Governance
Guidelines, the Charters of its Audit Committee,
Compensation Committee, Quality and
Compliance Committee, and Nominating and
Corporate Governance Committee and the
Company’s Code of Business Conduct and
Ethics are available on the Company’s website
at www.labcorp.com. You can also obtain a hard
copy of these documents, without charge, upon
written request to Paul Surdez, Laboratory
Corporation of America Holdings, 358 South
Main Street, Burlington, NC 27215.
Shareholder and Company Information BOARD OF DIRECTORS
David P. King
Chairman and Chief Executive Officer
Kerrii B. Anderson 1,4
Former Chief Executive Officer of
Wendy’s International, Inc.
Jean-Luc Bélingard 2,3
Chairman, bioMérieux S.A.
D. Gary Gilliland, M.D., Ph.D. 1,3
President & Director of the NCI-designated
Fred Hutchinson Cancer Research Center
Garheng Kong, M.D., Ph.D. 2,4
Managing Partner at Sofinnova HealthQuest Capital
Robert E. Mittelstaedt, Jr. 2,4
Dean Emeritus of the W. P. Carey School of Business
at Arizona State University
Peter M. Neupert 1,4
Operating Partner at Health Evolution Partners
Adam H. Schechter 2,3
Executive Vice President of Merck & Co., Inc. and the
President of Merck’s Global Human Health Division
R. Sanders Williams, M.D. 1,3
President of The J. David Gladstone Institutes
and Professor of Medicine at The University
of California San Francisco
Committees:
1 Audit
2 Compensation
3 Quality and Compliance
4 Nominating and Corporate Governance
Management Team
David P. King
Chairman and Chief Executive Officer
Glenn A. Eisenberg
Executive Vice President and
Chief Financial Officer
James T. Boyle, Jr.
Executive Vice President and
Chief Executive Officer, LabCorp Diagnostics
Joseph L. Herring
Chief Executive Officer,
Covance Drug Development
Lance V. Berberian
Senior Vice President and
Chief Information Officer
Edward T. Dodson
Senior Vice President and
Chief Accounting Officer
F. Samuel Eberts III
Senior Vice President, Chief Legal Officer
and Secretary
William E. Klitgaard
President, Enlighten Health
Lisa J. Uthgenannt
Chief Human Resources Officer